Page Banner

United States Department of Agriculture

Agricultural Research Service

Research Project: USING THE GENOME TO UNDERSTAND IMMUNOGENETICS OF POULTRY Title: Inhibition of avian tumor viruses by vector-based RNA interference

Authors
item Chen, MO - MICHIGAN STATE UNIVERSITY
item Payne, William - MICHIGAN STATE UNIVERSITY
item Hunt, Henry
item Zhang, Huanmin
item Holmen, Sheri - NEVADA CANCER INSTITUTE
item Dodgson, Jerry - MICHIGAN STATE UNIVERSITY

Submitted to: Plant and Animal Genome Conference
Publication Type: Abstract Only
Publication Acceptance Date: October 3, 2007
Publication Date: January 12, 2008
Citation: Chen, M., Payne, W.S., Hunt, H.D., Zhang, H., Holmen, S.L., Dodgson, J.B. 2008. Inhibition of avian tumor viruses by vector-based RNA interference [abstract]. Plant and Animal Genome Conference. p. 257.

Technical Abstract: RNA interference (RNAi) has been shown to reduce the replication of certain animal viruses both in cell culture and in live animals. We developed RNAi-based anti-viral strategies against two important chicken pathogens: avian leukosis virus (ALV) and Marek’s Disease virus MDV). Entry plasmids containing RNAi cassettes with structures similar to natural chicken primary microRNAs have been developed that can contain up to three target sequences simultaneously and easily can be moved into retroviral delivery vectors (RCAS). We showed that RNAi against the subgroup (B) ALV envelope gene (env(B)) and its host receptor gene (tvb) significantly reduced mRNA expression, protein expression and susceptibility to ALV(B) infection in cell culture. We demonstrated the specificity of antiviral RNAi using vectors with a doxycycline-regulated promoter. We further showed that retroviral based RNAi vectors can significantly inhibit the replication of MDV, both serotypes I and III, in cell culture. Retroviral vector-delivered RNAi targeting the viral glycoprotein gB gene and the ICP-4 gene reduced MDV titers and plaque size significantly. Other viral genes, such as UL49, are now being tested as targets. We are in the process of testing antiviral RNAi in birds into which the retroviral vectors have been introduced in the newly laid embryo, followed by incubation, hatching and challenge with virulent MDV. Viral replication is followed by titering and serology at various stages. Pathogenic effects of the virus are monitored throughout. Preliminary results suggest that retroviral vector-based RNAi may reduce MDV replication in lytic stage-infected birds.

Last Modified: 11/26/2014
Footer Content Back to Top of Page